| Top 50 Most Viewed Posts Last Week |
|---|
|
Today This Week Last Week This Month Last Month
|
| 1. Rosner: Short Interest Report As of Sat, Aug 3, '13 (2406) |
2. Cycl2R: I don’t believe it has been noted here that the (809)  (12) |
| 3. MJS719: Thank you brentie for the reminder of how (807) (10) |
| 4. Ganesha: Re: Current EIND policy at CYDY I wanted to let (735) (40) |
| 5. MGK_2: Patient A, is a 78-year-old female with a (733) (15) |
| 6. Katangolo: Dr. Melissa Palmer just posted this to her (718) (26) |
| 7. My69z: 3 yrs ago -- ICI Agreement with major institution (701) (8) |
| 8. MGK_2: To ohm or to anyone who might know, In the case (633) (6) |
| 9. My69z: New Dr. J video --- guess squeaky wheel gets (626) (13) |
| 10. twinter11: "LS-variant anti-CCR5 monoclonal antibody (623) (11) |
| 11. chazzledazzle: Lenacapavir (617) |
| 12. cardamine: PLEASE, NO! Mgmt *specifically* asked us to quit (587) (20) |
| 13. MIM-104: I concur. With so much going on, it's so clear to (580) (6) |
| 14. misiu143: We don't have BTD for mTNBC . Then , there is (560) (4) |
| 15. misiu143: CYDY submitted multiply application to FDA for (556) (15) |
| 16. KenChowder: Absolutely worth listening to. Around the 21:30 (545) (21) |
| 17. ohm20: Leronlimab lowers CTCs very early during (532) (12) |
| 18. Figgs: This today in BioSpace: Good article Nearly Three (532) (6) |
| 19. Nt2innvovate: What does everyone think about the fact that for (529) (4) |
| 20. MGK_2: Keen observation Figgs. I'd agree. Keeping (524) (7) |
| 21. BuckCYDYLong: Follow up: Fred is based in San Fran, but Sonoma (521) |
| 22. My69z: So they press released to us a for fee (517) (3) |
| 23. KenChowder: The FDA is not accepting BLAs or NDAs, BTDs or (516) (4) |
| 24. Respert24: I think many of us massively overestimate how (514) (27) |
| 25. Respert24: I think part of the answer lies within the (514) (17) |
| 26. My69z: Thank you very much.....for diggin in the crates (509) (2) |
| 27. over the rainbow: Sure he’s really gone? Methinks he might be the (508) (2) |
| 28. KenChowder: The FDA already granted leronlimab Fast Track (506) (3) |
| 29. Tprovo: The confidence really comes through in todays (505) (8) |
| 30. KenChowder: It was only confusing because I didn't realize (501) (9) |
| 31. misiu143: Hi Biloxi, I believe as you posted , when our (501) (15) |
| 32. Figgs: My area of expertise is the National Park Service (501) (5) |
| 33. KenChowder: The reason Leronlimab did not demonstrate a (499) (22) |
| 34. JimmyO: Jrt, I normally very much respect your opinion (495) (4) |
| 35. postal lady: I would have never held any shares from (21,) If (494) (3) |
| 36. mfglola: In January 2022, the FDA notified the Company (489) (8) |
| 37. Evil Rabbit: Smells like a bidding war in the next 1-6 months. (489) (8) |
| 38. Mr3Putt: The same video. How about on the CYDY web site (489) (5) |
| 39. mikeyt1818: You are correct Jimmy. I stopped posting for a (486) (8) |
| 40. Cassandra X: Here's a link to the PDF of the paper Melissa and (486) (4) |
| 41. twinter11: My reply was to a now deleted post by hygro or (479) (11) |
| 42. Mr3Putt: you completely missed the point of my post; I had (475) (7) |
| 43. Figgs: Massive layoffs of Fed workers during the (475) (8) |
| 44. biloxiblues: I just saw this article on LinkedIn. (474) (5) |
| 45. sean007: In conclusion, transforming immunologically (469) (1) |
| 46. sean007: Almost twice what is normally traded...All on (469) (3) |
| 47. Mr3Putt: I was pleased to hear in the vid Dr. J. saying (469) (5) |
| 48. misiu143: Oh no , immune system is awaken by LL , and (467) (9) |
| 49. BuckCYDYLong: Nobel prize in medicine announced for work in (467) (3) |
| 50. jrt03: Is it really hypocritical to feel frustrated in (463) (8) |
